Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users

American Journal of Psychiatry

Volumn 162, Issue 3, 2005, Pages 609-612

  Roiser, Jonathan P ^a   Cook, Lynnette J ^b   Cooper, Jason D ^b   Rubinsztein, David C ^b   Sahakian, Barbara J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMYL NITRATE; COCAINE; DIAMORPHINE; GENOMIC DNA; KETAMINE; LYSERGIDE; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AFFECT; AFFECTIVE GO NO GO TEST; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; DRUG ABUSE; EMOTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM; SEROTONINERGIC SYSTEM;

ADULT; AFFECTIVE SYMPTOMS; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE-RELATED DISORDERS; TRYPTOPHAN;

EID: 14844297080     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.3.609     Document Type: Article

References (21)

1. Ecstasy and Amphetamines: Global Survey 2003. Vienna, United Nations Office on Drugs and Crime, 2003
2. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 2003; 55:463-508
3. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W: Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001; 358:1864-1869
4. Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS: Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology 2000; 55:294-296
5. MacInnes N, Handley SL, Harding GF: Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 2001; 15:181-186
6. Cole JC, Sumnall HR: The BDI of the beholder (letter). J Psychopharmacol 2002; 16:103
7. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274:1527-1531
8. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC: Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 1998; 81:58-63
9. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M: Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998; 3:508-511
10. Nelson HE: National Adult Reading Test (NART): Test Manual. Windsor, UK, National Foundation for Educational Research-Nelson, 1982
11. Eysenck HJ, Eysenck SBG: Adult Impulsiveness, Venturesomeness and Empathy Scale. London, Hodder and Stoughton, 1991
12. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571
13. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES: Emotional bias and inhibitory control processes in mania and depression. Psychol Med 1999; 29: 1307-1321
14. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ: The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) 2002; 163:42-53
15. Rubinsztein JS, Rogers RD, Riedel WJ, Mehta MA, Robbins TW, Sahakian BJ: Acute dietary tryptophan depletion impairs maintenance of "affective set" and delayed visual recognition in healthy volunteers. Psychopharmacology (Berl) 2001; 154: 319-326
16. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ: The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl) 2004; 171:286-297
17. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ: The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 2002; 59:597-604
18. Matuszewich L, Filon ME, Finn DA, Yamamoto BK: Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine. Neuroscience 2002; 110:41-48
19. Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, Heninger GR, McDougle CJ: Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998; 19:26-35
20. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, Praschak-Rieder N, Zach J, de Zwann M, Bondy B, Ackenheil M, Kasper S: Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002; 59:613-620
21. Soar K, Turner JJ, Parrott AC: Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history. Hum Psychopharmacol 2001; 16: 641-645